IP Library Granted Patent US 7,160,251
Granted Patent B2
US 7,160,251 · App. 10/706,634 · Granted Jan 9, 2007

Systems and methods for blood glucose sensing

Assignee: Home Diagnostics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,160,251
App. No.
10/706,634
Granted
Jan 9, 2007
Kind
B2
Abstract

A system for measuring a glucose level in a blood sample includes a test strip and a meter. The test strip includes a sample chamber, a working electrode, a counter electrode, fill-detect electrodes, and an auto-on conductor. A reagent layer is disposed in the sample chamber. The auto-on conductor causes the meter to wake up and perform a test strip sequence when the test strip is inserted in the meter. The meter uses the working and counter electrodes to initially detect the blood sample in the sample chamber and uses the fill-detect electrodes to check that the blood sample has mixed with the reagent layer. The meter applies an assay voltage between the working and counter electrodes and measures the resulting current. The meter calculates the glucose level based on the measured current and calibration data saved in memory from a removable data storage device associated with the test strip.

Claims (58)

1. A method of measuring glucose in a blood sample, said method comprising:

providing a test strip, said test strip having a sample chamber, with a working electrode, a counter electrode, a pair of fill-detect electrodes, and a reagent layer disposed in said sample chamber, said reagent layer including glucose oxidase and a mediator, said test strip including an auto-on conductor;

inserting said test strip into a meter, said meter being in a sleep mode;

said meter detecting an auto-on current through said auto-on conductor and responsively entering an active mode;

said meter validating said working and counter electrodes by applying a first validation voltage between said working and counter electrodes;

said meter validating said fill-detect electrodes by applying a second validation voltage between said fill-detect electrodes, while said first validation voltage is applied between said working and counter electrodes;

applying said blood sample to said sample chamber;

said meter detecting said blood sample at a first location in said sample chamber by applying a drop-detect voltage between said working and counter electrodes and measuring a drop-detect current flowing between said working and counter electrodes;

said meter detecting said blood sample at a second location in said sample chamber by applying a fill-detect voltage between said fill-detect electrodes and measuring a fill-detect current flowing between said fill-detect electrodes;

after waiting an incubation time period, said meter applying an assay voltage between said working and counter electrodes and making at least one measurement of the resulting current through said working electrode; and

said meter determining a measured glucose level from said at least one current measurement.

2. The method of claim 1 , further comprising:

said auto-on current developing an auto-on voltage drop across said auto-on conductor; and

said meter measuring said auto-on voltage drop.

3. The method of claim 1 , further comprising:

said meter measuring any leakage current through said working electrode, while applying said first validation voltage between said working and counter electrodes; and

if said leakage current exceeds a first predetermined level, said meter indicating an error condition.

4. The method of claim 1 , further comprising:

said meter measuring any leakage current through one of said fill-detect electrodes, while applying said first validation voltage between said working and counter electrodes and said second validation voltage between said fill-detect electrodes; and

if said leakage current exceeds a second predetermined level, said meter indicating an error condition.

5. The method of claim 1 , further comprising:

if said drop-detect current does not reach a drop-detect threshold value within a predetermined time period, said meter indicating an error condition.

6. The method of claim 1 , further comprising:

if said drop-detect current reaches a drop-detect threshold value within a predetermined time period, said meter:

a) switching said working and counter electrodes to a high impedance state relative to said fill-detect electrodes;

b) starting a fill time period; and

c) starting said incubation time period.

7. The method of claim 6 , further comprising:

if said fill-detect current does not reach a fill-detect threshold value within said fill time period, said meter indicating an error condition.

8. The method of claim 6 , further comprising:

if said fill-detect current reaches a fill-detect threshold value within said fill time period, said meter providing a user-discernible indication.

9. A method of using a test strip to test a blood sample, said test strip including a sample chamber, a working electrode, a counter electrode, a pair of fill-detect electrodes, and an auto-on conductor, said method comprising:

inserting said test strip into a meter, said meter being in a sleep mode;

said meter detecting an auto-on current through said auto-on conductor and responsively entering an active mode;

said auto-on current developing an auto-on voltage drop across said auto-on conductor;

applying said blood sample to said sample chamber;

said meter detecting said blood sample in said sample chamber by applying a fill-detect voltage between said fill-detect electrodes and measuring a fill-detect current flowing between said fill-detect electrodes;

said meter applying an assay voltage between said working and counter electrodes and making at least one measurement of the resulting current; and

said meter determining a test result from said at least one current measurement.

10. The method of claim 9 , further comprising:

said meter measuring said auto-on voltage drop.

11. The method of claim 9 , further comprising:

if said fill-detect current reaches a fill-detect threshold value within a predetermined time period, said meter providing a user-discernible indication.

12. The method of claim 9 , further comprising:

said meter detecting said blood sample in said sample chamber by applying a drop-detect voltage between said working and counter electrodes and measuring a drop-detect current flowing between said working and counter electrodes.

13. The method of claim 12 , further comprising:

if said drop-detect current reaches a drop-detect threshold value within a predetermined time period, said meter starting an incubation time period.

14. The method of claim 13 , wherein said meter applies said assay voltage after said incubation time period.

15. The method of claim 9 , further comprising:

said meter validating said working and counter electrodes by applying a first validation voltage between said working and counter electrodes.

16. The method of claim 15 , further comprising:

said meter validating said fill-detect electrodes by applying a second validation voltage between said fill-detect electrodes, while said first validation voltage is applied between said working and counter electrodes.

17. The method of claim 9 , wherein:

said auto-on conductor is electrically isolated from said electrodes.

18. The method of claim 9 , wherein:

said test strip comprises a base layer, and said electrodes and said auto-on conductor comprise electrically conducting material disposed on said base layer.

19. The method of claim 9 , wherein:

said auto-on conductor is disposed on said test strip prior to said sample being applied.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: TRIVIDIA HEALTH, INC.
Reel/Frame 072743/0697 →
CHANGE OF NAME Recorded Mar 4, 2016
From: NIPRO DIAGNOSTICS, INC.
To: TRIVIDIA HEALTH, INC.
Reel/Frame 038002/0867 →
RELEASE OF SECURITY INTEREST Recorded Nov 5, 2013
From: REGIONS BANK
To: NIPRO DIAGNOSTICS, INC.
Reel/Frame 031581/0955 →
SECURITY AGREEMENT Recorded Nov 5, 2013
From: NIPRO DIAGNOSTICS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 031580/0094 →
SECURITY AGREEMENT Recorded Aug 24, 2012
From: NIPRO DIAGNOSTICS, INC.
To: REGIONS BANK
Reel/Frame 028840/0948 →
CHANGE OF NAME Recorded Jul 14, 2010
From: HOME DIAGNOSTICS, INC.
To: NIPRO DIAGNOSTICS, INC.
Reel/Frame 024678/0455 →
SECURITY AGREEMENT Recorded Mar 5, 2010
From: WACHOVIA BANK, NATIONAL ASSOCIATION
To: HOME DIAGNOSTICS, INC.
Reel/Frame 024035/0351 →
Continuity (6)
Division 1028664800 · Nov 1, 2002
Provisional Application 6037501700 · Apr 25, 2002
Provisional Application 6037501900 · Apr 25, 2002
Provisional Application 6037502000 · Apr 25, 2002
Provisional Application 6037505400 · Apr 25, 2002
Related Publication 20040094433A1 · May 20, 2004